JAN 11, 2020 7:34 PM PST

Molecular Therapy to Self-Repair Nerve Cells

WRITTEN BY: Amanda Mikyska

Neurodegenerative diseases such as Multiple Sclerosis (MS), Alzheimer's, and Huntington's Disease are predicated on damage to myelin on nerve cells.  Myelin smoothes nerve cells so that electrical signals can pass to and from the brain.  

New research from Mayo Clinic shows that in mouse models when the Protease Activated Receptor 1 (PAR1) is blocked, the nervous system repairs it's own myelin.  The PAR1 receptor produces the protein Thrombin when active, which promotes healing in moderate doses.  However, in high doses, Thrombin blocks precursor cells from differentiating into cells that replenish myelin.  

The study investigated the effect of blocking PAR1 in mice with short-term and long-term myelin deficiencies, mimicking the effect of different neurodegenerative disorders.  In both models, genetically turning off PAR1 was effective in increasing myelin and neuron regeneration.  

The Food and Drug Administration has already approved a PAR1 inhibitor for other purposes.  Currently, the PAR1 inhibitor is not approved for the treatment of neurodegenerative disorders because the proof of concept has only been tested in animal models, not a clinical setting.    Researchers are still excited about the results of this study because if a clinical trial is successful, the treatment can immediately be recommended to patients. 

 

Sources:  Yoon et. al., Science Daily

About the Author
  • Amanda graduated from the University of Massachusetts Boston with a degree in Biology. After working in research on creating biochemicals from genetically engineered yeast, she started freelance science writing while traveling the world. Now, Amanda is a Lab Manager and Research Assistant at the the University of Central Florida, studying the molecular phylogeny of parasitic wasps. She writes about the latest research in Neuroscience, Genetics & Genomics, and Immunology. Interested in working on solutions for food/water security, sustainable fuel, and sustainable farming. Amanda is an avid skier, podcast listener, and has run two triathlons.
You May Also Like
JAN 01, 2021
Cardiology
Blood Vessel Damage Caused by COVID-19 Disrupts Brain
JAN 01, 2021
Blood Vessel Damage Caused by COVID-19 Disrupts Brain
Scientists have been trying to determine if the SARS-CoV-2 virus infects brain cells directly, or if the virus severely ...
JAN 08, 2021
Neuroscience
Can We Identify Alzheimer's from Routine Eye Exams?
JAN 08, 2021
Can We Identify Alzheimer's from Routine Eye Exams?
As people with diabetes age, they are more likely than those without the condition to develop cognitive disorders such a ...
FEB 07, 2021
Genetics & Genomics
Insight Into a Disease-Related Protein in the Brain
FEB 07, 2021
Insight Into a Disease-Related Protein in the Brain
A protein called Gαo is found at high levels in the brain. Mutations in the gene that encodes Gαo cause dysfunctions in ...
FEB 06, 2021
Cannabis Sciences
Cannabis Reduces Disruptive Behavior in 50% of Young People with Autism
FEB 06, 2021
Cannabis Reduces Disruptive Behavior in 50% of Young People with Autism
Current pharmacotherapies for disruptive behaviors among those with autism are relatively ineffective. Now though, resea ...
APR 02, 2021
Genetics & Genomics
A New Neurodevelopmental Disorder is ID'ed
APR 02, 2021
A New Neurodevelopmental Disorder is ID'ed
Researchers have identified a genetic disease that causes neurodevelopmental disorders in some affected kids. The diseas ...
APR 14, 2021
Cell & Molecular Biology
Repairing Traumatic Brain Injuries with 'Brain Glue'
APR 14, 2021
Repairing Traumatic Brain Injuries with 'Brain Glue'
Brain injuries are common, costly, and difficult to treat. The brain damage that accompanies a significant traumatic bra ...
Loading Comments...